201 related articles for article (PubMed ID: 18085475)
1. Role of the MRP1/ABCC1 multidrug transporter protein in cancer.
Munoz M; Henderson M; Haber M; Norris M
IUBMB Life; 2007 Dec; 59(12):752-7. PubMed ID: 18085475
[TBL] [Abstract][Full Text] [Related]
2. Association of high-level MRP1 expression with poor clinical outcome in a large prospective study of primary neuroblastoma.
Haber M; Smith J; Bordow SB; Flemming C; Cohn SL; London WB; Marshall GM; Norris MD
J Clin Oncol; 2006 Apr; 24(10):1546-53. PubMed ID: 16575006
[TBL] [Abstract][Full Text] [Related]
3. The role of the multidrug resistance-associated protein 1 gene in neuroblastoma biology and clinical outcome.
Pajic M; Norris MD; Cohn SL; Haber M
Cancer Lett; 2005 Oct; 228(1-2):241-6. PubMed ID: 15979785
[TBL] [Abstract][Full Text] [Related]
4. ABC transporters and neuroblastoma.
Yu DM; Huynh T; Truong AM; Haber M; Norris MD
Adv Cancer Res; 2015; 125():139-70. PubMed ID: 25640269
[TBL] [Abstract][Full Text] [Related]
5. ABCC multidrug transporters in childhood neuroblastoma: clinical and biological effects independent of cytotoxic drug efflux.
Henderson MJ; Haber M; Porro A; Munoz MA; Iraci N; Xue C; Murray J; Flemming CL; Smith J; Fletcher JI; Gherardi S; Kwek CK; Russell AJ; Valli E; London WB; Buxton AB; Ashton LJ; Sartorelli AC; Cohn SL; Schwab M; Marshall GM; Perini G; Norris MD
J Natl Cancer Inst; 2011 Aug; 103(16):1236-51. PubMed ID: 21799180
[TBL] [Abstract][Full Text] [Related]
6. MYCN enhances P-gp/MDR1 gene expression in the human metastatic neuroblastoma IGR-N-91 model.
Blanc E; Goldschneider D; Ferrandis E; Barrois M; Le Roux G; Leonce S; Douc-Rasy S; Bénard J; Raguénez G
Am J Pathol; 2003 Jul; 163(1):321-31. PubMed ID: 12819037
[TBL] [Abstract][Full Text] [Related]
7. Importance of ABCC1 for cancer therapy and prognosis.
Kunická T; Souček P
Drug Metab Rev; 2014 Aug; 46(3):325-42. PubMed ID: 24670052
[TBL] [Abstract][Full Text] [Related]
8. Role of chemotherapy resistance genes in outcome of neuroblastoma.
de Cremoux P; Jourdan-Da-Silva N; Couturier J; Tran-Perennou C; Schleiermacher G; Fehlbaum P; Doz F; Mosseri V; Delattre O; Klijanienko J; Vielh P; Michon J
Pediatr Blood Cancer; 2007 Mar; 48(3):311-7. PubMed ID: 16609945
[TBL] [Abstract][Full Text] [Related]
9. ABCC1 G2012T single nucleotide polymorphism is associated with patient outcome in primary neuroblastoma and altered stability of the ABCC1 gene transcript.
Pajic M; Murray J; Marshall GM; Cole SP; Norris MD; Haber M
Pharmacogenet Genomics; 2011 May; 21(5):270-9. PubMed ID: 21317832
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide control of MYCN expression and multi drug resistance genes in tumours of neural origin.
Porro A; Chrochemore C; Cambuli F; Iraci N; Contestabile A; Perini G
Curr Pharm Des; 2010; 16(4):431-9. PubMed ID: 20236072
[TBL] [Abstract][Full Text] [Related]
11. MYCN-mediated regulation of the MRP1 promoter in human neuroblastoma.
Manohar CF; Bray JA; Salwen HR; Madafiglio J; Cheng A; Flemming C; Marshall GM; Norris MD; Haber M; Cohn SL
Oncogene; 2004 Jan; 23(3):753-62. PubMed ID: 14737110
[TBL] [Abstract][Full Text] [Related]
12. Targeting multidrug resistance-associated protein 1 (MRP1)-expressing cancers: Beyond pharmacological inhibition.
Hanssen KM; Haber M; Fletcher JI
Drug Resist Updat; 2021 Dec; 59():100795. PubMed ID: 34983733
[TBL] [Abstract][Full Text] [Related]
13. MRP1 and its role in anticancer drug resistance.
Lu JF; Pokharel D; Bebawy M
Drug Metab Rev; 2015; 47(4):406-19. PubMed ID: 26541366
[TBL] [Abstract][Full Text] [Related]
14. Multidrug-resistant tumor cells remain sensitive to a recombinant interleukin-4-Pseudomonas exotoxin, except when overexpressing the multidrug resistance protein MRP1.
de Jong MC; Scheffer GL; Broxterman HJ; Hooijberg JH; Slootstra JW; Meloen RH; Kreitman RJ; Husain SR; Joshi BH; Puri RK; Scheper RJ
Clin Cancer Res; 2003 Oct; 9(13):5009-17. PubMed ID: 14581376
[TBL] [Abstract][Full Text] [Related]
15. Two polymorphic variants of ABCC1 selectively alter drug resistance and inhibitor sensitivity of the multidrug and organic anion transporter multidrug resistance protein 1.
Conseil G; Cole SP
Drug Metab Dispos; 2013 Dec; 41(12):2187-96. PubMed ID: 24080162
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanism of ATP-dependent solute transport by multidrug resistance-associated protein 1.
Chang XB
Methods Mol Biol; 2010; 596():223-49. PubMed ID: 19949927
[TBL] [Abstract][Full Text] [Related]
17. Doxorubicin induces expression of multidrug resistance-associated protein 1 in human small cell lung cancer cell lines by the c-jun N-terminal kinase pathway.
Shinoda C; Maruyama M; Fujishita T; Dohkan J; Oda H; Shinoda K; Yamada T; Miyabayashi K; Hayashi R; Kawagishi Y; Fujita T; Matsui S; Sugiyama E; Muraguchi A; Kobayashi M
Int J Cancer; 2005 Oct; 117(1):21-31. PubMed ID: 15880572
[TBL] [Abstract][Full Text] [Related]
18. Functional and structural consequences of cysteine substitutions in the NH2 proximal region of the human multidrug resistance protein 1 (MRP1/ABCC1).
Leslie EM; Létourneau IJ; Deeley RG; Cole SP
Biochemistry; 2003 May; 42(18):5214-24. PubMed ID: 12731862
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of phosphatidylinositol 3-kinase destabilizes Mycn protein and blocks malignant progression in neuroblastoma.
Chesler L; Schlieve C; Goldenberg DD; Kenney A; Kim G; McMillan A; Matthay KK; Rowitch D; Weiss WA
Cancer Res; 2006 Aug; 66(16):8139-46. PubMed ID: 16912192
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic strategies for the treatment of neuroblastoma.
Izbicka E; Izbicki T
Curr Opin Investig Drugs; 2005 Dec; 6(12):1200-14. PubMed ID: 16370386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
